Page last updated: 2024-08-22

magnesium sulfate and Pulmonary Disease, Chronic Obstructive

magnesium sulfate has been researched along with Pulmonary Disease, Chronic Obstructive in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's6 (60.00)2.80

Authors

AuthorsStudies
Aye, SZ; Naing, C; Ni, H1
Gottlieb, M; Meissner, H; Moyer, E1
Gawrys, B; Silva, TW; Valerio, C1
Arnold, M; Raleigh, MF1
Habibzadeh, SR; Pishbin, E; Soltanifar, A; Talebi Doluee, M; Vafadar Moradi, E1
Ahidashti, HA; Amirifard, S; Jahanian, F; Khatir, IG1
Armstrong, P; Clayton-Smith, B; Hardy, M; Marchant, G; Marsh, E; Mukerji, S; Shahpuri, B; Smith, N1
Arseven, O; Cömert, Ş; Ece, T; İşsever, H; Kıyan, E; Okumuş, G1
Beasley, R; Edwards, L; Healy, B; Jefferies, S; Shirtcliffe, P; Wadsworth, K; Weatherall, M1
Abreu González, J; Abreu González, P; Hernández García, C; Jiménez, A; Martín García, C1

Reviews

1 review(s) available for magnesium sulfate and Pulmonary Disease, Chronic Obstructive

ArticleYear
Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
    The Cochrane database of systematic reviews, 2022, 05-26, Volume: 5

    Topics: Disease Progression; Dyspnea; Humans; Ipratropium; Magnesium; Magnesium Sulfate; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic

2022

Trials

6 trial(s) available for magnesium sulfate and Pulmonary Disease, Chronic Obstructive

ArticleYear
The Adjunctive Effect of Intravenous Magnesium Sulfate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2021, Volume: 28, Issue:3

    Topics: Acute Disease; Asthma; Double-Blind Method; Humans; Magnesium Sulfate; Pulmonary Disease, Chronic Obstructive

2021
The Effect of Intravenous Magnesium Sulphate as an Adjuvant in the Treatment of Acute Exacerbations of COPD in the Emergency Department: A Double-Blind Randomized Clinical Trial.
    Ethiopian journal of health sciences, 2021, Volume: 31, Issue:2

    Topics: Double-Blind Method; Emergency Service, Hospital; Forced Expiratory Volume; Humans; Magnesium Sulfate; Pulmonary Disease, Chronic Obstructive

2021
Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study.
    The New Zealand medical journal, 2015, Nov-20, Volume: 128, Issue:1425

    Topics: Administration, Inhalation; Administration, Intravenous; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Hydrocortisone; Ipratropium; Magnesium Sulfate; Male; Middle Aged; Oxygen Inhalation Therapy; Pilot Projects; Prednisone; Pulmonary Disease, Chronic Obstructive; Vital Capacity

2015
[Efficiency of nebulised magnesium sulphate in infective exacerbations of chronic obstructive pulmonary disease].
    Tuberkuloz ve toraks, 2016, Volume: 64, Issue:1

    Topics: Administration, Inhalation; Aged; Calcium Channel Blockers; Female; Follow-Up Studies; Humans; Magnesium Sulfate; Male; Middle Aged; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests

2016
Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial.
    Thorax, 2013, Volume: 68, Issue:4

    Topics: Aged; Albuterol; Bronchodilator Agents; Disease Progression; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Intention to Treat Analysis; Ipratropium; Magnesium Sulfate; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive

2013
[Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease exacerbations requiring hospitalization: a randomized placebo-controlled trial].
    Archivos de bronconeumologia, 2006, Volume: 42, Issue:8

    Topics: Acute Disease; Bronchi; Bronchodilator Agents; Double-Blind Method; Hospitalization; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive

2006

Other Studies

3 other study(ies) available for magnesium sulfate and Pulmonary Disease, Chronic Obstructive

ArticleYear
What Is the Role of Magnesium Sulfate for Acute Exacerbations of Chronic Obstructive Pulmonary Disease?
    Annals of emergency medicine, 2023, Volume: 81, Issue:5

    Topics: Acute Disease; Bronchodilator Agents; Disease Progression; Humans; Magnesium Sulfate; Pulmonary Disease, Chronic Obstructive

2023
Magnesium Sulfate Infusion to Prevent Hospitalization for Acute COPD Exacerbations.
    American family physician, 2022, Volume: 106, Issue:5

    Topics: Disease Progression; Hospitalization; Humans; Magnesium Sulfate; Pulmonary Disease, Chronic Obstructive

2022
Addition of Magnesium Sulfate for Acute COPD Exacerbations.
    American family physician, 2023, Volume: 108, Issue:4

    Topics: Asthma; Disease Progression; Humans; Magnesium Sulfate; Pulmonary Disease, Chronic Obstructive

2023